CGEN logo

Compugen Ltd.

CGEN
Healthcare|Biotechnology|IL
$1.96
+0.04 (+2.08%)
Tangible Book / Share
$0.94
Graham Number
$2.80
Cash / Share
$1.32
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest May 18, 2026 (F-3). Possible dilution.

Upcoming Data Readouts (2)

Mar 2027
Est. completion
P1P2Ovarian Cancer
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
Nov 2027
Est. completion
P1Neoplasm
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

SEC Filings (24)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 10, 20266-KForeign issuer reportDocumentIndex
Aug 3, 20266-KForeign issuer reportDocumentIndex
Aug 3, 20266-KForeign issuer reportDocumentIndex
Jun 8, 2026EFFECTDocumentIndex
May 18, 2026F-3Shelf registrationDocumentIndex
May 18, 20266-KForeign issuer reportDocumentIndex
Mar 2, 202620-FAnnual report (foreign)DocumentIndex
Mar 2, 20266-KForeign issuer reportDocumentIndex
Feb 12, 20266-KForeign issuer reportDocumentIndex
Dec 17, 20256-KForeign issuer reportDocumentIndex
Nov 10, 20256-KForeign issuer reportDocumentIndex
Oct 14, 20256-KForeign issuer reportDocumentIndex
Sep 17, 20256-KForeign issuer reportDocumentIndex
Aug 6, 20256-KForeign issuer reportDocumentIndex
Aug 6, 20256-KForeign issuer reportDocumentIndex
Jul 21, 20256-KForeign issuer reportDocumentIndex
May 19, 20256-KForeign issuer reportDocumentIndex
May 13, 20256-KForeign issuer reportDocumentIndex
Mar 4, 202520-FAnnual report (foreign)DocumentIndex
Mar 4, 20256-KForeign issuer reportDocumentIndex
Feb 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jan 8, 20256-KForeign issuer reportDocumentIndex
Nov 27, 20246-KForeign issuer reportDocumentIndex
Nov 12, 20246-KForeign issuer reportDocumentIndex